Literature DB >> 32060727

Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.

Manuela Curcio1, Paola Avena2, Giuseppe Cirillo2, Ivan Casaburi2, Umile Gianfranco Spizzirri2, Fiore Pasquale Nicoletta2, Francesca Iemma2, Vincenzo Pezzi2.   

Abstract

PURPOSE: Solid tumors exhibit an altered redox state in comparison with normal tissues due to tumor hypoxia, lower pH, and elevated levels of the tripeptide glutathione. This study describes the preparation of functional redox-responsive nanoparticles proposed as delivery vehicle of Doxorubicin in adrenocortical cancer in vitro.
METHODS: Curcumin and Lipoic acid were conjugated to Human Serum Albumin and nanoparticle systems were prepared via a modified desolvation method. Scanning electron microscopy, Fourier transmission IR, dynamic light scattering and differential scanning calorimetry analyses were used to characterize the nanoparticles. Balb3T3 and H295R were used as in vitro models of health and cancer cells, respectively.
RESULTS: Nanoparticles with a spherical shape and a mean diameter of 70 nm were observed, increasing up to ten-folds upon exposure to glutathione 10 mM. Redox responsive Doxorubicin release was recorded, with loaded nanoparticles significantly enhancing the drug cytotoxicity against H295R adrenocortical tumor cells. Cell uptake experiments revealed a rapid and efficient internalization of the nanoparticles.
CONCLUSIONS: A valuable tools to actively improve the in vitro anticancer activity of Doxorubicin against adrenocortical cancer was proposed. The effectiveness of the delivery vehicle is related to the presence of both Lipoic acid and Curcumin moieties, enhancing the glutathione responsivity, and the drug cytotoxicity, respectively.

Entities:  

Keywords:  adrenocortical carcinoma; curcumin conjugate; human serum albumin nanoparticles; redox-responsive

Mesh:

Substances:

Year:  2020        PMID: 32060727     DOI: 10.1007/s11095-020-2775-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

Review 1.  Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy.

Authors:  Keywan Mortezaee; Ensieh Salehi; Hanifeh Mirtavoos-Mahyari; Elahe Motevaseli; Masoud Najafi; Bagher Farhood; Rhonda J Rosengren; Amirhossein Sahebkar
Journal:  J Cell Physiol       Date:  2019-01-08       Impact factor: 6.384

2.  Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma.

Authors:  R D Schulick; M F Brennan
Journal:  Ann Surg Oncol       Date:  1999-12       Impact factor: 5.344

Review 3.  Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy.

Authors:  Bagher Farhood; Keywan Mortezaee; Nasser Hashemi Goradel; Neda Khanlarkhani; Ensieh Salehi; Maryam Shabani Nashtaei; Masoud Najafi; Amirhossein Sahebkar
Journal:  J Cell Physiol       Date:  2018-10-14       Impact factor: 6.384

4.  Preclinical investigation of nanoparticle albumin-bound paclitaxel as a potential treatment for adrenocortical cancer.

Authors:  Michael J Demeure; Elizabeth Stephan; Shripad Sinari; David Mount; Steven Gately; Paul Gonzales; Galen Hostetter; Richard Komorowski; Jeff Kiefer; Clive S Grant; Haiyong Han; Daniel D Von Hoff; Kimberly J Bussey
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

5.  Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids.

Authors:  Arturo Castro Nava; Monica Cojoc; Claudia Peitzsch; Giuseppe Cirillo; Ina Kurth; Susanne Fuessel; Kati Erdmann; David Kunhardt; Orazio Vittorio; Silke Hampel; Anna Dubrovska
Journal:  Int J Cancer       Date:  2015-06-25       Impact factor: 7.396

6.  Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles.

Authors:  Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Fathollah Tahmasebi; Fazel Shokri
Journal:  Int J Pharm       Date:  2013-02-27       Impact factor: 5.875

7.  Hydrophobically Modified Keratin Vesicles for GSH-Responsive Intracellular Drug Release.

Authors:  Manuela Curcio; Barbara Blanco-Fernandez; Luis Diaz-Gomez; Angel Concheiro; Carmen Alvarez-Lorenzo
Journal:  Bioconjug Chem       Date:  2015-08-26       Impact factor: 4.774

8.  Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.

Authors:  Robhash Kusam Subedi; Keon Wook Kang; Hoo-Kyun Choi
Journal:  Eur J Pharm Sci       Date:  2009-05-03       Impact factor: 4.384

9.  Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.

Authors:  Montserrat Ayala-Ramirez; Sina Jasim; Lei Feng; Shamim Ejaz; Ferhat Deniz; Naifa Busaidy; Steven G Waguespack; Aung Naing; Kanishka Sircar; Christopher G Wood; Lance Pagliaro; Camilo Jimenez; Rena Vassilopoulou-Sellin; Mouhammed Amir Habra
Journal:  Eur J Endocrinol       Date:  2013-10-23       Impact factor: 6.664

Review 10.  Manipulation and exploitation of the tumour environment for therapeutic benefit.

Authors:  I J Stratford; G E Adams; J C Bremner; S Cole; H S Edwards; N Robertson; P J Wood
Journal:  Int J Radiat Biol       Date:  1994-01       Impact factor: 2.694

View more
  1 in total

1.  Dual-Targeted Hyaluronic Acid/Albumin Micelle-Like Nanoparticles for the Vectorization of Doxorubicin.

Authors:  Manuela Curcio; Luis Diaz-Gomez; Giuseppe Cirillo; Fiore Pasquale Nicoletta; Antonella Leggio; Francesca Iemma
Journal:  Pharmaceutics       Date:  2021-02-26       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.